Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€52.40
29.03.23
€58.10
29.03.24
22.14%
30.03.24

Bank of America Co. 
29.03.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.78
11.03.24
€28.00
11.03.25
6.63%
28.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
11.03.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€736.80
23.03.23
€791.57
23.03.24
20.86%
24.03.24

EF Hutton Acquisition Co. I 
23.03.23 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.35
21.03.23
€11.13
21.03.24
122.05%
22.03.24

BTIG Research 
21.03.23 50%
buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€230.25
13.03.23
€263.70
13.03.24
28.83%
14.03.24

Stephens 
13.03.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€219.90
13.03.23
€247.40
13.03.24
14.78%
14.03.24

Wells Fargo & Company 
13.03.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€307.70
13.03.23
€350.10
13.03.24
124.73%
14.03.24

Wells Fargo & Company 
13.03.23 50%
sell
Invitae Corp

Start price
Target price
Perf. (%)
€1.30
11.03.23
€0.40
11.03.24
-93.65%
12.03.24

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
11.03.23 60%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€41.80
09.03.23
€54.81
09.03.24
45.22%
10.03.24

JPMorgan Chase & Co. 
09.03.23 50%
buy
Universal Health Services B

Start price
Target price
Perf. (%)
€117.92
06.03.23
€135.81
06.03.24
37.38%
07.03.24

Deutsche Bank Aktiengesellschaft 
06.03.23 50%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.86
06.03.23
€173.60
06.03.24
26.85%
07.03.24

Needham & Company LLC 
06.03.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24

Chardan Capital 
03.03.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€299.80
03.03.23
€339.30
03.03.24
142.83%
04.03.24

Citigroup Inc. 
03.03.23 50%
buy
Universal Health Services B

Start price
Target price
Perf. (%)
€120.22
03.03.23
€143.96
03.03.24
33.92%
04.03.24

Credit Suisse Group AG 
03.03.23 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€18.54
24.06.23
€27.00
31.12.25
347.68%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€38.80
02.03.23
€45.28
02.03.24
71.39%
03.03.24

The Goldman Sachs Group, Inc. 
02.03.23 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€23.20
02.03.23
€33.06
02.03.24
69.83%
03.03.24

LADENBURG THALM/SH SH 
02.03.23 50%
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€4.06
02.03.23
€14.17
02.03.24
612.84%
03.03.24

HC Wainwright 
02.03.23 50%
buy
IVERIC bio Inc.

Start price
Target price
Perf. (%)
€23.20
02.03.23
€33.06
02.03.24
56.90%
03.03.24

HC Wainwright 
02.03.23 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€23.20
02.03.23
€30.22
02.03.24
69.83%
03.03.24

Needham & Company LLC 
02.03.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€40.60
01.03.23
€54.33
01.03.24
63.79%
02.03.24

Needham & Company LLC 
01.03.23 50%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€167.56
28.02.23
€159.97
28.02.24
25.57%
29.02.24

Guggenheim 
28.02.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€77.50
28.02.23
€95.04
28.02.24
93.55%
29.02.24

Guggenheim 
28.02.23 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.32
28.02.23
€1.88
28.02.24
-50.72%
29.02.24

The Goldman Sachs Group, Inc. 
28.02.23 50%